219 related articles for article (PubMed ID: 25212528)
21. Esophagectomy performed at institutes certified by the Japan Esophageal Society provide long-term survival advantages to esophageal cancer patients: second report analyzing 4897 cases with propensity score matching.
Motoyama S; Maeda E; Yano M; Yasuda T; Ohira M; Kajiyama Y; Higashi T; Doki Y; Matsubara H
Esophagus; 2020 Apr; 17(2):141-148. PubMed ID: 31939000
[TBL] [Abstract][Full Text] [Related]
22. Consequences of Refusing Surgery for Esophageal Cancer: A National Cancer Database Analysis.
Rahouma M; Harrison S; Kamel M; Nasar A; Lee B; Port J; Altorki N; Stiles B
Ann Thorac Surg; 2018 Nov; 106(5):1476-1483. PubMed ID: 30055137
[TBL] [Abstract][Full Text] [Related]
23. Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer.
Haisley KR; Hart KD; Nabavizadeh N; Bensch KG; Vaccaro GM; Thomas CR; Schipper PH; Hunter JG; Dolan JP
Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475724
[TBL] [Abstract][Full Text] [Related]
24. Comparison of survival among neoadjuvant chemoradiation responders, non-responders and patients receiving primary resection for locally advanced oesophageal squamous cell carcinoma: does neoadjuvant chemoradiation benefit all?
Hsu PK; Chien LI; Huang CS; Hsieh CC; Wu YC; Hsu WH; Chou TY
Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):460-6. PubMed ID: 23728085
[TBL] [Abstract][Full Text] [Related]
25. Outcome of delayed versus timely esophagectomy after chemoradiation for esophageal adenocarcinoma.
Levinsky NC; Wima K; Morris MC; Ahmad SA; Shah SA; Starnes SL; Van Haren RM;
J Thorac Cardiovasc Surg; 2020 Jun; 159(6):2555-2566. PubMed ID: 31767364
[TBL] [Abstract][Full Text] [Related]
26. No Survival Difference with Neoadjuvant Chemoradiotherapy Compared with Chemotherapy in Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma: Results from the National Cancer Data Base.
Al-Sukhni E; Gabriel E; Attwood K; Kukar M; Nurkin SJ; Hochwald SN
J Am Coll Surg; 2016 Dec; 223(6):784-792.e1. PubMed ID: 27641320
[TBL] [Abstract][Full Text] [Related]
27. Association Between Clinically Staged Node-Negative Esophageal Adenocarcinoma and Overall Survival Benefit From Neoadjuvant Chemoradiation.
Gabriel E; Attwood K; Du W; Tuttle R; Alnaji RM; Nurkin S; Malhotra U; Hochwald SN; Kukar M
JAMA Surg; 2016 Mar; 151(3):234-45. PubMed ID: 26559488
[TBL] [Abstract][Full Text] [Related]
28. Post-treatment mortality after definitive chemoradiotherapy versus resection for esophageal cancer.
Jiang W; Verma V; Haque W; Moreno AC; Koshy M; Butler EB; Teh BS
Dis Esophagus; 2020 Apr; 33(4):. PubMed ID: 31504359
[TBL] [Abstract][Full Text] [Related]
29. A Propensity-matched Analysis Comparing Survival After Esophagectomy Followed by Adjuvant Chemoradiation to Surgery Alone for Esophageal Squamous Cell Carcinoma.
Hwang JY; Chen HS; Hsu PK; Chao YK; Wang BY; Huang CS; Liu CC; Wu SC
Ann Surg; 2016 Jul; 264(1):100-6. PubMed ID: 26649580
[TBL] [Abstract][Full Text] [Related]
30. Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis.
Nomura M; Oze I; Kodaira T; Abe T; Komori A; Narita Y; Masuishi T; Taniguchi H; Kadowaki S; Ura T; Andoh M; Tachibana H; Uemura N; Tajika M; Niwa Y; Muto M; Muro K
Int J Clin Oncol; 2016 Oct; 21(5):890-898. PubMed ID: 26980212
[TBL] [Abstract][Full Text] [Related]
31. A propensity-score matching analysis comparing long-term survival of surgery alone and postoperative treatment for patients in node positive or stage III esophageal squamous cell carcinoma after R0 esophagectomy.
Yu S; Zhang W; Ni W; Xiao Z; Wang Q; Zhou Z; Feng Q; Zhang H; Chen D; Liang J; Lv J; Hui Z; He J; Gao S; Sun K; Fang D; Liu X; Li Y
Radiother Oncol; 2019 Nov; 140():159-166. PubMed ID: 31302346
[TBL] [Abstract][Full Text] [Related]
32. Surgery Is Associated With Survival Benefit in T4a Esophageal Adenocarcinoma: A National Analysis.
Raman V; Jawitz OK; Voigt SL; Farrow NE; Yang CJ; D'Amico TA; Harpole DH
Ann Thorac Surg; 2019 Dec; 108(6):1633-1639. PubMed ID: 31356800
[TBL] [Abstract][Full Text] [Related]
33. Drivers of 30- and 90-day Postoperative Death After Neoadjuvant Chemoradiation for Esophageal Cancer.
Horne ZD; Wegner RE; Colonias A; Weksler B; Glaser SM; Kalash R; Beriwal S
Ann Thorac Surg; 2020 Mar; 109(3):921-926. PubMed ID: 31846643
[TBL] [Abstract][Full Text] [Related]
34. Esophagectomy versus endoscopic resection for patients with early-stage esophageal adenocarcinoma: A National Cancer Database propensity-matched study.
Marino KA; Sullivan JL; Weksler B
J Thorac Cardiovasc Surg; 2018 May; 155(5):2211-2218.e1. PubMed ID: 29455958
[TBL] [Abstract][Full Text] [Related]
35. Impact of surgical approach on perioperative and long-term outcomes following esophagectomy for esophageal cancer.
Ahmadi N; Crnic A; Seely AJ; Sundaresan SR; Villeneuve PJ; Maziak DE; Shamji FM; Gilbert S
Surg Endosc; 2018 Apr; 32(4):1892-1900. PubMed ID: 29067584
[TBL] [Abstract][Full Text] [Related]
36. Intensity-modulated radiotherapy at high-volume centers improves survival in patients with esophageal adenocarcinoma receiving trimodality therapy.
Yang GQ; Mhaskar R; Rishi A; Naghavi AO; Frakes JM; Almhanna K; Fontaine J; Pimiento JM; Hoffe SE
Dis Esophagus; 2019 Aug; 32(8):. PubMed ID: 30597022
[TBL] [Abstract][Full Text] [Related]
37. Induction chemotherapy or chemoradiotherapy followed by radical esophagectomy for T4 esophageal cancer: results of a prospective cohort study.
Shimoji H; Karimata H; Nagahama M; Nishimaki T
World J Surg; 2013 Sep; 37(9):2180-8. PubMed ID: 23649529
[TBL] [Abstract][Full Text] [Related]
38. National guidelines may reduce socioeconomic disparities in treatment selection for esophageal cancer.
Nobel TB; Lavery JA; Barbetta A; Gennarelli RL; Lidor AO; Jones DR; Molena D
Dis Esophagus; 2019 May; 32(5):. PubMed ID: 30496376
[TBL] [Abstract][Full Text] [Related]
39. Definitive chemoradiation therapy or surgery for clinical T1-3N0-1M0 thoracic esophageal squamous cell carcinoma: A propensity score matching analysis.
Li XY; Luo HS; Wu SX; Du ZS; Zheng CP; Wu ZY
Asian J Surg; 2019 Jan; 42(1):350-355. PubMed ID: 29802029
[TBL] [Abstract][Full Text] [Related]
40. Influence of facility volume on long-term survival of patients undergoing esophagectomy for esophageal cancer.
Patel DC; Jeffrey Yang CF; He H; Liou DZ; Backhus LM; Lui NS; Shrager JB; Berry MF
J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1536-1546.e3. PubMed ID: 34247867
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
